Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
Background The prevalence of chronic pain in children and adolescents is high. In some patients, it can be severe and refractory to conventional treatment options. There is increasing interest in the use of cannabinoids for therapeutic purposes in children and adolescents. Nabilone, a synthetic cann...
Saved in:
Main Authors: | Naiyi Sun (Author), Natasha Cunha (Author), Shawnee Amar (Author), Stephen Brown (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical expirience in opioid switch for noncancer chronic pain treatment
by: F. J. López-Pérez, et al.
Published: (2014) -
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023) -
A Scoping Review of Gaps Identified by Primary Care Providers in Caring for Patients with Chronic Noncancer Pain
by: Virginia McEwen, et al.
Published: (2023) -
Acute Synthetic Cannabinoid Toxicity Simulation
by: Paolo Grenga, et al.
Published: (2015) -
Atrial fibrillation following synthetic cannabinoid abuse
by: Tolga Han Efe, et al.
Published: (2017)